Superstarch and Physical/Cognitive Performance Following a Simulated Soccer Game

NCT ID: NCT02667340

Last Updated: 2016-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the efficacy of a hydrothermally modified starch supplement (Superstarch made byGeneration UCAN) vs isoenergetic placebo (glucose) on exercise performance, execution of specific soccer skills, and on cognitive function during and following a simulated soccer game.

Secondary: To compare fat oxidation and carbohydrate oxidation (based on RER data) during the game with Generation UCAN vs isoenergetic placebo (glucose).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a double blind cross over study. There will be two treatments involved: Superstarch and glucose (placebo). Participants and investigators will be blinded as an individual not involved in the project will prepare and distribute the treatment (drinks) according to a coding system that is kept confidential until the study is completed. Participants will complete each treatment once and the treatment order will be systematically rotated to avoid any order effect. Healthy men and women soccer players aged 18-35 yr will be recruited. Participants will come to the lab on five different occasions to complete two familiarization sessions, a baseline testing session, and two main trials. During the first visit, the participants will be asked to complete a physical activity readiness questionnaire (as approved previously; Par Q and a participant information form for personal and familial health history to rule out any pathologies or health issues that may preclude them from participating in the present study. Subsequently, the investigators will collect data for VO2max, body composition and sprinting speed. In the second visit, participants will be familiarized with the high intensity intermittent exercise protocol to be used during the study days and will also be allowed to practice the cognitive and skill tests to be used (up to 8 times in order to remove any learning effect that may influence the results). During the third visit, baseline scores for the skill tests will be collected. Participants will perform 4 attempts (the first two will be for re-acclimation) and the last two will be recorded. The remaining two visits will be the study days and will be separated by at least 1 week. The order of treatments will be randomized to avoid any order effect. The night before study day, participants will arrive at the laboratory at 19:00 h and will be fed a standardized meal containing 2g/kg of carbohydrate (pasta and tomato sauce) and will not be allowed any food or drink except water thereafter. On the study day, participants will arrive to the lab at 07:30 h following an overnight 12h fast and will have refrained from exercise, caffeine or alcohol within the prior 24 hours. Baseline capillary blood lactate and blood glucose will be obtained by fingerprick by a trained phlebotomist. In order to ensure the prevention of infection and or contamination during sampling, standard sterile blood handling techniques will be used including the use of new medical examination gloves, alcohol swabs, and disposable sterile lancets. All blood-contaminated materials will be disposed of in a hazardous material labeled disposal (or sharps) container, promptly after analysis. Subsequently, baseline data for the cognitive tests will be collected. After collecting baseline data, the corresponding treatment will be given and 30 minutes after, participants will perform a standardized 10-minute warm-up, followed by the exercise session. The exercise session consists of a 60- minute simulated soccer game divided into 4 x 15-minute blocks exercising (running) at varying intensities that replicate the activity pattern of soccer such as sprinting, jogging, cruising, walking etc. The proportion of time spent at each speed will be allocated based on a time-motion analysis of professional soccer players observed by Reilly and Thomas (1976) as indicated by Clarke et al (2008). During each 15-minute block, cognitive function will be tested using the serial seven subtraction test and the Flanker test. Also, expired gas samples will be collected during the last 4 min of each standardized 15-minute block to estimate carbohydrate and fat oxidation. A fingerprick blood lactate and blood glucose sample will be collected at the end of each 15-minute block. Ratings of perceived exertion will also be taken at the end of each block. Water will be available ad-libitum during the first test day and will be quantified. The same amount of water will be provided for the remaining trial. After completion of the 60-minute simulated soccer game, we will test physical performance using a repeated sprint ability test comprised of twelve, 30m sprints with 35sec of walking recovery between each sprint. Subsequently, technical skills will be assessed using a battery test comprised of the Slalom Dribble test and the Loughborough Soccer Passing Test (LSPT). The Slalom Dribble test is a skill test that requires participants to dribble a soccer ball around a set obstacle course taking the least amount of time possible whereas the LSPT is a test that requires participants to accurately pass a soccer ball a set number of times towards coloured targets while negotiating a coned area, as quickly as possible.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effect of Superstarch on Soccer Performance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Superstarch

Supplementation with Superstarch before a simulated soccer game

Group Type EXPERIMENTAL

Superstarch

Intervention Type DIETARY_SUPPLEMENT

0.7 g Superstarch or placebo per kg body mass in two ingestions (before game \& at halftime)

Placebo

Supplementation with placebo before simulated soccer game.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

0.7 g glucose per kg body mass in two ingestions (before game \& at halftime)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Superstarch

0.7 g Superstarch or placebo per kg body mass in two ingestions (before game \& at halftime)

Intervention Type DIETARY_SUPPLEMENT

Placebo

0.7 g glucose per kg body mass in two ingestions (before game \& at halftime)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

UCan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy male and female elite soccer players who are involved in regular soccer training
* aged 15-35 years

Exclusion Criteria

* Smoker
* taking part in other research
* have a neurological or psychiatric condition that may cause cognitive dysfunction
* for women, if they are pregnant or become pregnant during the study
* Injury limiting exercise ability
Minimum Eligible Age

15 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Western Ontario, Canada

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Lemon

PhD. Weider Research Chair

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pete W Lemon, PhD

Role: PRINCIPAL_INVESTIGATOR

Western University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pete w Lemon, PhD

Role: CONTACT

519-661-2111 ext. 88139

Manuel Quinones, B.ASc

Role: CONTACT

519-661-2111 ext. 88164

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10009797

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Speed of Glucose Absorption
NCT06375577 COMPLETED NA
Carbohydrate Ingestion Prior to Surgery (CIPS)
NCT06057532 ACTIVE_NOT_RECRUITING NA